| Literature DB >> 32960813 |
Paul Bastard1,2,3, Jeremy Manry1,2, Jie Chen3, Jérémie Rosain1,2, Yoann Seeleuthner1,2, Omar AbuZaitun4, Lazaro Lorenzo1,2, Taushif Khan5, Mary Hasek3, Nicholas Hernandez3, Benedetta Bigio3, Peng Zhang3, Romain Lévy1,2,6, Shai Shrot7,8, Eduardo J Garcia Reino3, Yoon-Seung Lee3, Soraya Boucherit1,2, Mélodie Aubart1,9, Rik Gijsbers10, Vivien Béziat1, Zhi Li11, Sandra Pellegrini11, Flore Rozenberg12, Nico Marr5,13, Isabelle Meyts14,15,16, Bertrand Boisson1,2,3, Aurélie Cobat1,2, Jacinta Bustamante1,2,3,17, Qian Zhang3, Emmanuelle Jouangy1,2,3, Laurent Abel1,2,3, Raz Somech18,8, Jean-Laurent Casanova1,2,3,6,19, Shen-Ying Zhang1,2,3.
Abstract
Inborn errors of TLR3-dependent IFN-α/β- and IFN-λ-mediated immunity in the CNS can underlie herpes simplex virus 1 (HSV-1) encephalitis (HSE). The respective contributions of IFN-α/β and IFN-λ are unknown. We report a child homozygous for a genomic deletion of the entire coding sequence and part of the 3'-UTR of the last exon of IFNAR1, who died of HSE at the age of 2 years. An older cousin died following vaccination against measles, mumps, and rubella at 12 months of age, and another 17-year-old cousin homozygous for the same variant has had other, less severe, viral illnesses. The encoded IFNAR1 protein is expressed on the cell surface but is truncated and cannot interact with the tyrosine kinase TYK2. The patient's fibroblasts and EBV-B cells did not respond to IFN-α2b or IFN-β, in terms of STAT1, STAT2, and STAT3 phosphorylation or the genome-wide induction of IFN-stimulated genes. The patient's fibroblasts were susceptible to viruses, including HSV-1, even in the presence of exogenous IFN-α2b or IFN-β. HSE is therefore a consequence of inherited complete IFNAR1 deficiency. This viral disease occurred in natural conditions, unlike those previously reported in other patients with IFNAR1 or IFNAR2 deficiency. This experiment of nature indicates that IFN-α/β are essential for anti-HSV-1 immunity in the CNS.Entities:
Keywords: Cytokines; Genetic diseases; Immunology; Infectious disease; Innate immunity
Year: 2021 PMID: 32960813 PMCID: PMC7773360 DOI: 10.1172/JCI139980
Source DB: PubMed Journal: J Clin Invest ISSN: 0021-9738 Impact factor: 14.808